PT - JOURNAL ARTICLE AU - Nicastro, Fabrizio AU - Sironi, Giorgia AU - Antonello, Elio AU - Bianco, Andrea AU - Biasin, Mara AU - Brucato, John R. AU - Ermolli, Ilaria AU - Pareschi, Giovanni AU - Salvati, Marta AU - Tozzi, Paolo AU - Trabattoni, Daria AU - Clerici, Mario TI - Solar UV–B/A Radiation is Highly Effective in Inactivating SARS-CoV-2 AID - 10.1101/2020.06.03.20121392 DP - 2021 Jan 01 TA - medRxiv PG - 2020.06.03.20121392 4099 - http://medrxiv.org/content/early/2021/07/10/2020.06.03.20121392.short 4100 - http://medrxiv.org/content/early/2021/07/10/2020.06.03.20121392.full AB - Solar UV-C photons do not reach Earth’s surface, but are known to be endowed with germicidal properties that are also effective on viruses. The effect of softer UV-B and UV-A photons, which copiously reach the Earth’s surface, on viruses are instead little studied, particularly on single-stranded RNA viruses.Here we combine our measurements of the action spectrum of Covid-19 in response to UV light, Solar irradiation measurements on Earth during the SARS-CoV-2 pandemics, worldwide recorded Covid-19 mortality data and our “Solar-Pump” diffusive model of epidemics to show that (a) UV-B/A photons have a powerful virucidal effect on the single-stranded RNA virus Covid-19 and that (b) the Solar radiation that reaches temperate regions of the Earth at noon during summers, is sufficient to inactivate 63% of virions in open-space concentrations (1.5×103 TCID50/mL, higher than typical aerosol) in less than 2 minutes.We conclude that the characteristic seasonality imprint displayed world-wide by the SARS-Cov-2 mortality time-series throughout the diffusion of the outbreak (with temperate regions showing clear seasonal trends and equatorial regions suffering, on average, a systematically lower mortality), might have been efficiently set by the different intensity of UV-B/A Solar radiation hitting different Earth’s locations at different times of the year.Our results suggest that Solar UV-B/A play an important role in planning strategies of confinement of the epidemics, which should be worked out and set up during spring/summer months and fully implemented during low-solar-irradiation periods.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Milano INAFAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesFor the UV illumination data we used public data provided by the TEMIS network http://www.temis.nl/ SARS-CoV-2 data are taken by the GitHub repository provided by the Coronavirus Resource Center of the John Hopkins University: https://github.com/CSSEGISandData/COVID-19